Abstract:PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) is the 4 leading cause of U.S. cancer-related mortality. Currently, patients with PDAC have a dismal prognosis due to a complete lack of effective therapies . Dendritic cells (DC) are one of the most potent antigen-presenting cells (APCs) in the immune system. Development of therapeutic cancer vaccines using DCs loaded with tumor antigens which are transferred to a host enhancing its tumor immune response, is a viable treatment option, however clinical trials have failed to achieve good efficacy. One of the major roadblocks to the development of these immune therapies is the inability to assess effective target acquisition. In this work we demonstrate that ironoxide labeled DCs, loaded with antigens, can be effectively tracked as they “home in” on the lymph nodes 3 . By providing direct MR visualization of DC uptake in lymph node environment one can positively confirm target acquisition and explore the underlying mechanisms more in depth, The research conducted in this work will the development of these cancer vaccines for translational applications METHODS Panc-2 tumor cells (~2 × 10 cells ) were implanted in both right and left flank female C57BL/6 mice and allowed to grow to palpable nodule (~3-5 mm). Bone marrow derived DCs were prepared as described in [1]. After antigen loading as described in [23] DCs were labeled with biocompatible iron nanoparticles FeOLabel-TexasRed (GENOVIS AB, Lund Sweden) as prescribed. Characterization was conducted to evaluate percent of iron and viability of labeled DCs. Iron amount was estimated by MR relaxometry using variable concentration phantoms (0-10 μg/ml). Vaccine administration was performed by injecting the labeled DCs in the left hind footpad of the mice (Three groups: 1) 1e6 cells, 2) 2e6 cells and 3) no cells as control) All MRI experiments (in vitro and ex vivo) were carried out on a Bruker 7 T (Clinscan, Ettlingen, Germany) using multiple spin echo and multiple gradient echo sequences to obtain coronal and axial images of the bilateral popliteal LNs and to generate corresponding parametric maps (Slice Thickness=0.2 mm In plane resolution 0.14 mm) . Animals were scanned at 6 hours and 24 hours after injection of DCs. All physiological parameters were maintained during experiments as prescribed by institutional ACUC standards. Ex vivo assessment of DC loading in popliteal LN was conducted using histological methods for validation of MRI images. Anti-Tumor efficacy of DCs was evaluated using standard vital signs and by measuring tumor volume at different time points following tumor implantation (1,5,10,15,20,25,35 days). RESULTS & DISCUSSION: Shown in Figure 1(a-c) are three coronal T2W images of bilateral popliteal LN’s at different times (a) preinjection of DC’s, (b) 6 hour post and (c) 24 hour post. The left LN exhibits clear signal decrease consistent with migration of iron labeled DC’s (injected in left footpad) while right is unaffected. Prussian blue staining of bilateral popliteal LNs are shown in Fig 1 (d) Right and Fig 1(e) Left, confirming presence of SPIO labeled DC’s in the later (Fig 1(f) is a blow up of region). Also shown in Fig 2 are the tumor size longitudinal measurements for control group compared to group A (1e6 DC’s) and group B (2e6 DC’s) demonstrating the therapeutic efficacy of the treatment

Gadolinium-doped Au@prussian blue nanoparticles as MR/SERS bimodal agents for dendritic cell activating and tracking

Magnetic resonance and near-infrared imaging using a novel dual-modality nano-probe for dendritic cell tracking in vivo.

Superparamagnetic MRI Probes for in Vivo Tracking of Dendritic Cell Migration with a Clinical 3 T Scanner.

The Migration of Synthetic Magnetic Nanoparticle Labeled Dendritic Cells into Lymph Nodes with Optical Imaging

Negatively Charged Magnetite Nanoparticle Clusters as Efficient MRI Probes for Dendritic Cell Labeling and In Vivo Tracking

Lactosylated N-Alkyl Polyethylenimine Coated Iron Oxide Nanoparticles Induced Autophagy in Mouse Dendritic Cells.

In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide.

Lymph Node Metastases Detection Using Gd2O3@PCD as Novel Multifunctional Contrast Imaging Agent in Metabolic Magnetic Resonance Molecular Imaging

Multifunctional Low-Generation Dendrimer Nanogels As an Emerging Probe for Tumor-Specific CT/MR Dual-Modal Imaging

Multifunctional Dendrimer-Entrapped Gold Nanoparticles for Labeling and Tracking T Cells Via Dual-Modal Computed Tomography and Fluorescence Imaging

Magnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer Immunotherapy.

Multifunctional Dendrimer-Based Nanoparticles for in Vivo MR/CT Dual-Modal Molecular Imaging of Breast Cancer

Gadolinium-functionalized aggregation-induced emission dots as dual-modality probes for cancer metastasis study.

Improving the MR Imaging Sensitivity of Upconversion Nanoparticles by an Internal and External Incorporation of the Gd(3+) Strategy for in Vivo Tumor-Targeted Imaging.

6617 In vivo cellular MRI monitoring of FeO Labeled DC-based cancer vaccine for immunotherapeutic treatment of pancreatic cancer

Synthesis and Testing of Modular Dual-Modality Nanoparticles for Magnetic Resonance and Multispectral Photoacoustic Imaging

Application of Gold Nanorods for Plasmonic and Magnetic Imaging of Cancer Cells

Dendritic cells reprogrammed by CEA messenger RNA loaded multi-functional silica nanospheres for imaging-guided cancer immunotherapy

AuGd integrated nanoprobes for optical/MRI/CT triple-modal in vivo tumor imaging.

MR and optical imaging of early micrometastases in lymph nodes: triple labeling with nano-sized agents yielding distinct signals

The MRI-Visible Nanocomposite Facilitates the Delivery and Tracking of siRNA Loaded DC Vaccine in the Breast Cancer Model